ATLANTA—Georgia State University has unveiled its newest state-of-the-art research facility, the Research Science Center, to support biomedical research.
The $45 million building will house up to four principal investigators per research floor and their faculty and staff, as well as postdoctoral scholars, graduate students and undergraduate students. The center, constructed without the use of state taxpayer funds, is at the corner of Decatur Street SE and Piedmont Avenue SE downtown.
Researchers in the five-floor building will share one common open lab area with 10 support rooms and three collaborative areas on a pedestrian walkway linking the fifth floor of the center to the adjacent Petit Science Center.
“The Research Science Center is another tremendous resource for Georgia State to meet the health care challenges of the 21st century,” said James Weyhenmeyer, vice president for research and economic development at Georgia State. “The advanced facility will allow our researchers to continue playing a key role in bringing scientific innovations into the everyday practices and policies that directly affect people’s lives and the health of communities.”
Occupying the top two floors is Georgia State’s Center for Molecular and Translational Medicine (CMTM). CMTM researchers transform information gained from biomedical research into knowledge improving the state of human health and disease. The research focus of the center is to dissect molecular insights of cardiovascular remodeling in obesity and obesity-related diseases, including diabetes, hypertension, heart diseases and stroke, with special emphasis on the regulation of these processes.
“CMTM meets healthcare needs by converting significant research findings into diagnostic tools and medicines to improve the health of individuals,” said Ming-Hui Zou, Georgia Research Alliance Eminent Scholar and director of the Center for Molecular and Translational Medicine. “The center is designed to help millions of people suffering from heart disease, diabetes and other illnesses.”
Georgia State’s Center for Translational Immunology (CTI) within the university’s Institute for Biomedical Sciences (IBMS) is housed on the third floor of the Research Science Center. CTI is devoted to translational bench-to-bedside research targeting some of the most pressing health challenges of the 21st century, including immunological disorders such as autoimmune diseases, infectious diseases, inflammatory diseases, cancer, cardiovascular disease and metabolic diseases.
“CTI researchers are dedicated to developing game-changing immunological therapies that can transform human health,” said Jian-Dong Li, professor and director of IBMS at Georgia State and a Georgia Research Alliance Eminent Scholar. “Our new, cutting-edge core facilities, including immune imaging core and translational immunology core harboring, are some of the most sophisticated imaging and immunology equipment devices that will empower our scientists to rapidly translate groundbreaking discoveries into the most advanced patient care.”